SG11201900522SA - Composition for promoting ketone body production - Google Patents
Composition for promoting ketone body productionInfo
- Publication number
- SG11201900522SA SG11201900522SA SG11201900522SA SG11201900522SA SG11201900522SA SG 11201900522S A SG11201900522S A SG 11201900522SA SG 11201900522S A SG11201900522S A SG 11201900522SA SG 11201900522S A SG11201900522S A SG 11201900522SA SG 11201900522S A SG11201900522S A SG 11201900522SA
- Authority
- SG
- Singapore
- Prior art keywords
- composition
- ketone body
- body production
- promoting ketone
- promoting
- Prior art date
Links
- 150000002576 ketones Chemical class 0.000 title 1
- 230000001737 promoting effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Nutrition Science (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Psychology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016161267A JP6935994B2 (en) | 2016-08-19 | 2016-08-19 | Composition for promoting ketone body production |
PCT/JP2017/029587 WO2018034330A1 (en) | 2016-08-19 | 2017-08-18 | Composition for promoting ketone body formation |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201900522SA true SG11201900522SA (en) | 2019-02-27 |
Family
ID=61196762
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201900522SA SG11201900522SA (en) | 2016-08-19 | 2017-08-18 | Composition for promoting ketone body production |
SG10202101629TA SG10202101629TA (en) | 2016-08-19 | 2017-08-18 | Composition for promoting ketone body production |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10202101629TA SG10202101629TA (en) | 2016-08-19 | 2017-08-18 | Composition for promoting ketone body production |
Country Status (8)
Country | Link |
---|---|
US (2) | US11224581B2 (en) |
EP (2) | EP3501516A4 (en) |
JP (1) | JP6935994B2 (en) |
CN (1) | CN109803646A (en) |
CA (1) | CA3033908A1 (en) |
SG (2) | SG11201900522SA (en) |
TW (1) | TWI749050B (en) |
WO (1) | WO2018034330A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3111573A1 (en) * | 2018-09-24 | 2020-04-02 | Tastes Natural, Llc | Process for isolating taste-modifiers |
EP3855941A1 (en) * | 2018-10-04 | 2021-08-04 | Ajinomoto Co., Inc. | Leucine-enriched ketogenic formulations |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3486778B2 (en) * | 1993-04-02 | 2004-01-13 | 三菱ウェルファーマ株式会社 | Alzheimer's disease preventive / treatment agent |
DE19528461A1 (en) * | 1995-08-03 | 1997-02-06 | Braun Melsungen Ag | Preparation for nutrition |
CA2611389C (en) * | 2005-07-29 | 2015-02-17 | Tima Foundation | Composition for moderating alcohol metabolism and for reducing the risk of alcohol induced diseases |
KR101634083B1 (en) | 2006-04-03 | 2016-06-28 | 액세라인크 | Use of ketogenic compounds for treatment of age-associated memory impairment |
JP5173230B2 (en) * | 2007-04-03 | 2013-04-03 | 株式会社明治 | Amino acid composition and food and drink |
US20080286254A1 (en) * | 2007-05-17 | 2008-11-20 | Kaneka Corporation | Composition comprising licorice polyphenol |
JP2009261335A (en) * | 2008-04-25 | 2009-11-12 | Tsujido Chemical Corp | Food composition |
JP2011136948A (en) * | 2009-12-28 | 2011-07-14 | Nisshin Oillio Group Ltd | Oil-and-fat composition for prevention or treatment of depression or depressed state |
ITRM20100679A1 (en) * | 2010-12-21 | 2012-06-22 | Aniello Antimo D | D-ASPARTIC ACID, L-ASPARTIC ACID, THEIR SALTS OR THEIR COMBINATIONS FOR THE RESTORATION OF THE COGNITIVE ACTIVITY AND OF THE MEMORY IN THE ALZHEIMER'S DISEASES AND IN OTHER SENILE DEEDS. |
WO2012113415A1 (en) * | 2011-02-24 | 2012-08-30 | N.V. Nutricia | Ketogenic diet composition for the treatment of chemo therapy and/or radiation therapy patients |
CN105050594B (en) * | 2013-03-19 | 2019-11-12 | 南佛罗里达大学 | For generating the composition and method that increase with lasting ketosis |
WO2015034812A2 (en) * | 2013-09-04 | 2015-03-12 | Beth Israel Deaconess Medical Center | A new ketogenic diet and its use in treating the critically ill |
CN106535919A (en) * | 2014-07-23 | 2017-03-22 | 般财团法人粮食研究会 | Brain function improving agent, and prophylactic or therapeutic agent for cognitive dysfunction |
JP6507365B2 (en) | 2015-03-05 | 2019-05-08 | パナソニックIpマネジメント株式会社 | Range food |
JP2016210720A (en) | 2015-05-07 | 2016-12-15 | 治 江▲崎▼ | Motor function improving agent, respiratory function improving agent, or cognitive ability improving agent |
-
2016
- 2016-08-19 JP JP2016161267A patent/JP6935994B2/en active Active
-
2017
- 2017-08-18 EP EP17841552.7A patent/EP3501516A4/en not_active Withdrawn
- 2017-08-18 EP EP22190716.5A patent/EP4144348A1/en active Pending
- 2017-08-18 US US16/326,260 patent/US11224581B2/en active Active
- 2017-08-18 TW TW106128061A patent/TWI749050B/en active
- 2017-08-18 CA CA3033908A patent/CA3033908A1/en active Pending
- 2017-08-18 SG SG11201900522SA patent/SG11201900522SA/en unknown
- 2017-08-18 CN CN201780049740.6A patent/CN109803646A/en active Pending
- 2017-08-18 SG SG10202101629TA patent/SG10202101629TA/en unknown
- 2017-08-18 WO PCT/JP2017/029587 patent/WO2018034330A1/en unknown
-
2021
- 2021-12-06 US US17/542,996 patent/US20220151966A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
TW201818829A (en) | 2018-06-01 |
CN109803646A (en) | 2019-05-24 |
SG10202101629TA (en) | 2021-03-30 |
JP6935994B2 (en) | 2021-09-15 |
EP3501516A1 (en) | 2019-06-26 |
WO2018034330A1 (en) | 2018-02-22 |
CA3033908A1 (en) | 2018-02-22 |
EP4144348A1 (en) | 2023-03-08 |
EP3501516A4 (en) | 2020-07-29 |
US20190183828A1 (en) | 2019-06-20 |
US20220151966A1 (en) | 2022-05-19 |
JP2018027923A (en) | 2018-02-22 |
US11224581B2 (en) | 2022-01-18 |
TWI749050B (en) | 2021-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUE047226T2 (en) | Moulding body and method for its production | |
GB201612853D0 (en) | Solid dosage form production | |
PL3241646T3 (en) | Production line | |
ZA201902125B (en) | Process for the production of 2-alkylalkanol | |
GB201603358D0 (en) | Nanoparticle production | |
SG11201704737SA (en) | Novel aqueous composition | |
IL248267A0 (en) | Process for the preparation of substituted cycloserines | |
ZA201808135B (en) | Process for making micro-aerated choco-material | |
SG11201704740WA (en) | Aqueous composition | |
PL3160985T3 (en) | Process for the production of d-arginyl-2,6-dimethyl-l-tyrosyl-l-lysyl-l-phenylalaninamide | |
PT3183355T (en) | Biological processes for the production of aryl sulfates | |
GB201506074D0 (en) | Object production | |
PL3392307T3 (en) | Process for producing polyacetal resin composition | |
SG11201900522SA (en) | Composition for promoting ketone body production | |
HK1220986A1 (en) | Gold decor composition with selected metal composition as well as method for the production thereof | |
PL3174402T3 (en) | Process for the manufacture of dairy powder | |
SG11201805486QA (en) | Method for producing hydroxypivalaldehyde | |
HUE055317T2 (en) | Process for making isoidide | |
IL247443B (en) | Process for the preparation of 5-fluorotryptophol | |
SG11201702202UA (en) | Aqueous composition | |
GB2546925B (en) | Phantom production tool | |
GB2532451B (en) | Object production | |
IL262889B (en) | Process for the manufacture of 6-alkynyl-pyridine derivatives | |
GB201607927D0 (en) | Composition & process | |
GB201610646D0 (en) | X-ray micro-beam production |